MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2022 International Congress

    Impact of foslevodopa/foscarbidopa on key clinical and patient-reported outcomes in patients with aPD: Responder analysis of two Phase 3 clinical trials

    M. Soileau, J. Aldred, A. Antonini, C. Carroll, V. Fung, T. Henriksen, R. Pahwa, D. Santos Garcia, A. Epstein, C. Yan, A. Alobaidi, A. Shewale, A. Spiegel, M. Facheris, J. Zamudio, P. Kukreja, KR. Chaudhuri (Georgetown, USA)

    Objective: To evaluate the effect of foslevodopa/foscarbidopa (LDP/CDP, ABBV-951) on clinical and patient-reported outcomes in advanced Parkinson’s disease (aPD) patients using minimal clinically important difference…
  • 2022 International Congress

    Monogenic Hub of the Global Parkinson’s Genetics Program (GP2): In search of new PD genes

    L. Lange, ZH. Fang, E. Valente, SY. Lim, A. Tan, A. Illarionova, M. Avenali, I. Keller Sarmiento, H. Madoev, K. Roopnarain, C. Galandra, M. Ellis, K. Kumar, P. Heutink, N. Mencacci, K. Lohmann, C. Klein (Lübeck, Germany)

    Objective: To identify novel monogenic causes of Parkinson’s disease (PD) by performing short and long-read sequencing for up to 10,000 PD patients and families with…
  • 2022 International Congress

    Heart rate variability is affected by standing and medication intake in Parkinson’s disease

    F. Cucinotta, F. Morgante, I. Cociasu, E. Pereira, E. Makovac, L. Ricciardi (London, United Kingdom)

    Objective: To evaluate the effect of levodopa and orthostatism on heart rate variability (HRV) in a sample of consecutive subjects with Parkinson's disease (PD). Background:…
  • 2022 International Congress

    Olfactory Network Reorganization in Parkinson’s Disease

    L. Pesantez Pacheco, M. Saqib, D. Ehrlich, M. Hallett, S. Horovitz (Bethesda, USA)

    Objective: To explore changes in the organization and functionality of the olfactory network in patients with Parkinson’s Disease (PD) using graph theory-based network analysis on…
  • 2022 International Congress

    Connectivity matrices for differentiating voluntary stopping states and involuntary freezing states in Parkinson’s disease

    D. Salgado, A. Pineda, C. Alves, R. Carra, F. Rodrigues, M. Souza, R. Cury (São Paulo, Brazil)

    Objective: The present study aims to demonstrate a possible application of the analysis of functional brain connectivity from brain connectivity matrices. Specifically, we aim to: - Differentiate…
  • 2022 International Congress

    Studying Care Patterns and Support Preferences Among People Living with Parkinson’s Disease

    C. Pearson, M. Feeney, A. Willis, N. Yarab, R. Dolhun, V. Todaro, S. Rosenfeld (Chicago, USA)

    Objective: To understand health care utilization among Medicare beneficiaries living with Parkinson’s Disease (PD) and how care patterns differ across demographic groups. Background: Optimal care…
  • 2022 International Congress

    Satisfaction level: quality of life, motor and non-motor symptoms outcomes of Mexican PD patients after deep brain stimulation.

    P. Bazán-Rodríguez, E. Reséndiz-Henríquez, E. Ichikawa-Escamilla, AJ. Hernández-Medrano, GI. Cerda-Hernández, MA. Ruiz-Mafud, L. Bazán-Rodríguez, C. Martínez-Cortés, RA. Abundes-Corona, A. Cervantes-Arriaga, M. Rodríguez-Violante (Mexico City, Mexico)

    Objective: To evaluate satisfaction level and quality of life in Mexican PD patients after undergoing deep brain stimulation surgery using a structured questionnaire assessimg motor…
  • 2022 International Congress

    The Edmond J. Safra Fellowship in Movement Disorders: A Global Network of Parkinson’s Experts

    R. Dolhun (New York, USA)

    Objective: To train more movement disorder clinician-researchers around the world to meet growing care and research needs in Parkinson’s and related disorders. Background: Care from…
  • 2022 International Congress

    Impact of ApoE genotype on cognition in idiopathic and genetic forms of Parkinson’s disease

    C. Koros, K. Brockmann, Aμ. Simitsi, A. Bougea, H. Liu, ακ. Hauser, C. Schulte, I. Pachi, N. Papagiannakis, A. Zahou, I. Wurster, E. Efthymiopoulou, I. Beratis, R. Antonelou, M. Maniati, M. Moraitou, H. Michelakakis, G. Paraskevas, S. Papageorgiou, C. Potagas, D. Papadimitriou, M. Bozi, M. Stamelou, T. Gasser, L. Stefanis (Athens, Greece)

    Objective: The aim of our current report was to assess the impact of Apolipoprotein-E (ApoE) genotype on cognition in idiopathic Parkinson’s disease (PD) patients and…
  • 2022 International Congress

    Cognitive performance and learning parameters predict response to working memory training in Parkinson’s disease

    A. Ophey, J. Wenzel, R. Paul, K. Giehl, C. Eggers, P. Reker, T. van Eimeren, E. Kalbe, L. Kambeitz-Ilankovic (Cologne, Germany)

    Objective: The present study aims to evaluate a multivariable model to predict verbal working memory (WM) performance following a targeted cognitive training intervention, WM training…
  • « Previous Page
  • 1
  • …
  • 200
  • 201
  • 202
  • 203
  • 204
  • …
  • 338
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • An atypical and interesting feature of Parkinson´s disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • An atypical and interesting feature of Parkinson´s disease
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley